Recludix Pharma to Present at the Oppenheimer Private Life Sciences Company Showcase

ConferenceNeutral

AI Analysis

Summary

Recludix Pharma announced it will present at the Oppenheimer Private Life Sciences Company Showcase on September 29, 2026, with CEO Nancy Whiting and R&D head Ajay Nirula discussing the company's inhibitor programs for inflammatory disease.

Importance:2/10

Sentiment:

0.00

conferencepresentationclinical-stageinflammatory disease

Read the original article

Published by GlobeNewswire Clinical Studies on September 22, 2026 12:00 PM

Read Original